Evidence map›Paper›PMID 28544732›Full record

ArticleBipolar disorders2017

Similar familial underpinnings for full and subsyndromal pediatric bipolar disorder: A familial risk analysis.

Janet Wozniak, Mai Uchida, Stephen V Faraone, Maura Fitzgerald, Carrie Vaudreuil, Nicholas Carrellas, Jacqueline Davis, Rebecca Wolenski, Joseph Biederman

Abstract read
In one paragraph

Article in Bipolar disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Janet WozniakClinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA.
Mai UchidaClinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA.
Stephen V FaraoneSUNY Upstate Medical University, Syracuse, NY, USA.
Maura FitzgeraldClinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA.
Carrie VaudreuilClinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA.
Nicholas CarrellasClinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA.
Jacqueline DavisClinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA.
Rebecca WolenskiClinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA.
Joseph BiedermanClinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-8233-663X

Funding

OUTCOME OF ATTENTION DEFICIT HYPERACTIVITY DISORDERR01HD036317 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI BIEDERMAN, JOSEPH · 1998 to 2007
$4.0M
Longitudinal Family Study of Pediatric Bipolar DisorderR01MH066237 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI WOZNIAK, JANET · 2003 to 2007
$2.9M
LONGITUDINAL FOLLOW UP OF ADHD GIRLS AND THEIR SIBLINGSR01MH050657 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BIEDERMAN, JOSEPH · 1993 to 2002
$1.5M
Neural, Inflammatory, and Genomic Mechanisms Underlying Risk for Depression in AdolescenceK08MH103443 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SLAVICH, GEORGE MICHAEL · 2015 to 2018
$772k
DEVELOPMENTAL SUBTYPES OF JUVENILE BIPOLAR DISORDERK08MH001503 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI WOZNIAK, JANET · 1997 to 2001
$312k
NICHD NIH HHS R01 HD036317NIMH NIH HHS K08 MH001503NIMH NIH HHS K08 MH103443NIMH NIH HHS R01 MH050657NIMH NIH HHS R01 MH066237
6 · The paper itself

Abstract

objectivesTo examine the validity of subthreshold pediatric bipolar I disorder (BP-I), we compared the familial risk for BP-I in the child probands who had either full BP-I, subthreshold BP-I, ADHD, or were controls that neither had ADHD nor bipolar disorder.

methodsBP-I probands were youth aged 6-17 years meeting criteria for BP-I, full (N=239) or subthreshold (N=43), and also included were their first-degree relatives (N=687 and N=120, respectively). Comparators were youth with ADHD (N=162), controls without ADHD or bipolar disorder (N=136), and their first-degree relatives (N=511 and N=411, respectively). We randomly selected 162 non-bipolar ADHD probands and 136 non-bipolar, non-ADHD control probands of similar age and sex distribution to the BP-I probands from our case-control ADHD family studies. Psychiatric assessments were made by trained psychometricians using the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children Epidemiological Version (KSADS-E) and Structured Clinical Interview for DSM-IV (SCID) structured diagnostic interviews. We analyzed rates of bipolar disorder using multinomial logistic regression.

resultsRates of full BP-I significantly differed between the four groups (χ

conclusionsOur results showed that youth with subthreshold BP-I had similarly elevated risk for BP-I and major depressive disorder in first-degree relatives as youth with full BP-I. These findings support the diagnostic continuity between subsyndromal and fully syndromatic states of pediatric BP-I disorder.

Indexed as

Bipolar DisorderAdolescentAsymptomatic DiseasesCase-Control StudiesChildDiagnostic and Statistical Manual of Mental DisordersFemaleHumansMaleMassachusettsMedical History TakingPsychiatric Status Rating ScalesRandom AllocationRisk AssessmentRisk Factorschildrenfamilialitypediatric bipolar disordersubsyndromal

Identifiers

PMID28544732
PMCPMC5510949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.